Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2009-12-22

FDA Approved: AMPICILLIN AND SULBACTAM — Original Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approved Hikma's Ampicillin and Sulbactam as an Original Application (AND A065406), a generic antibiotic combining ampicillin with sulbactam for several inf…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AMPICILLIN AND SULBACTAM (AMPICILLIN SODIUM AND SULBACTAM SODIUM)

Snippet

ORIG AP for AMPICILLIN AND SULBACTAM (AMPICILLIN AND SULBACTAM)